Abstract
This review identifies and quantifies general (ie, nongenetic) risk factors for all-cause dementia, Alzheimer's disease, and vascular dementia specifically.
| Original language | English |
|---|---|
| Pages (from-to) | 341-347 |
| Number of pages | 7 |
| Journal | Alzheimer's and Dementia |
| Volume | 3 |
| Issue number | 4 |
| DOIs | |
| Publication status | Published - Oct 2007 |
Bibliographical note
Funding Information:Chris MacKnight has received support from Alzheimer Society of Nova Scotia (Board Member), Janssen-Ortho (Speaker, Trial Investigator), Pfizer Canada (Speaker, Trial Investigator), Novartis (Speaker, Trial Investigator), Lundbeck Canada (Speaker, Trial Investigator), Voyager Pharmaceuticals (Trial Investigator), Myriad (Trial Investigator), and Neurochem (Trial Investigator).
Funding Information:
During preparation of this article, Christopher Patterson received financial support from the Institute of Advanced Studies, University of Bologna, Bologna, Italy.
Funding Information:
Chris MacKnight is supported from a CIHR New Investigator Award.
ASJC Scopus Subject Areas
- Epidemiology
- Health Policy
- Developmental Neuroscience
- Clinical Neurology
- Geriatrics and Gerontology
- Psychiatry and Mental health
- Cellular and Molecular Neuroscience
PubMed: MeSH publication types
- Journal Article
